BHVN•benzinga•
Biohaven Says Data From Phase 1 Of BHV-1300 Shows Rapid And Deep Reductions In Total IgG, For The Potential Treatment Of Autoimmune Disease
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 3, 2025 by benzinga